Numerous investigations support decreased glutamatergic signaling as a pathogenic mechanism of schizophrenia, yet the molecular underpinnings for such dysregulation are largely unknown. In the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback